カリフォルニア州における肺疾患の臨床試験
カリフォルニア州内の拠点で、肺疾患に関する30件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles10件の研究
- San Francisco5件の研究
- Orange4件の研究
- Newport Beach4件の研究
- Baldwin Park3件の研究
- Torrance3件の研究
- Long Beach3件の研究
- Mountain View3件の研究
- San Diego3件の研究
- Concord3件の研究
公式研究テキスト（英語）
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05624450Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Hoag Hospital Newport Beach, Newport Beach
- University of California, Irvine Health, Orange
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- 他9件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Stanford Cancer Institute, Stanford
- Stanford Hospital and Clinics, Stanford
- Stanford Hospital Investigational Drug Services, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245American Lung Association (ALA) Lung Health Cohort
- University of California, Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
被験者募集中観察研究健康なボランティア歓迎
25歳〜35歳 · 全性別 · 2026/09/23更新 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Antelope Valley Clinical Trials, Lancaster
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- 他2件
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Orange
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Cedars-Sinai Medical Center, Los Angeles
- BASS Cancer Center, Walnut Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/03更新 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Santa Barbara
- Clinical Research Site, Torrance
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- City of Hope - Duarte, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT05967689A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Bakersfield
- Research Site, Lancaster
- Research Site, Long Beach
- 他1件
被験者募集中第2相
4歳〜11歳 · 全性別 · 2026/08/27更新 · NCT07525375Understanding New Cachexia Subtypes Through Observational Epidemiological Research
- Kaiser Permanente Northern California, Pleasanton
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/20更新 · NCT07776353A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/11更新 · NCT07555483A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
被験者募集中第4相健康なボランティア歓迎
18歳〜64歳 · 全性別 · 2026/08/07更新 · NCT07730450Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of California, Los Angeles, Los Angeles
被験者募集中観察研究健康なボランティア歓迎
25歳〜35歳 · 全性別 · 2026/07/17更新 · NCT06177717A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- The Angeles Clinic and Research Institute, Los Angeles
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/06/11更新 · NCT05361174BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Stanford University School of Medicine, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/10更新 · NCT05922761A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- 他5件
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
被験者募集中
40歳〜90歳 · 全性別 · 2025/12/01更新 · NCT05572632Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of California-Los Angeles, Los Angeles
被験者募集中
18歳以上 · 全性別 · 2025/09/29更新 · NCT04555161Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
被験者募集中第1/2相健康なボランティア歓迎
18歳以上 · 全性別 · 2022/04/29更新 · NCT04684602ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。